AR
DXCM icon

Advisory Research’s DexCom DXCM Stock Holding History

Advisory Research’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,280
Closed -$231K – 314
2020
Q2 		$231K Sell
2,280
-5,084
-69% -$455K 0.02% 300
2020
Q1 		$496K Sell
7,364
-5,588
-43% -$348K 0.03% 193
2019
Q4 		$708K Sell
12,952
-7,368
-36% -$349K 0.03% 210
2019
Q3 		$758K Buy
20,320
+7,968
+65% +$310K 0.04% 217
2019
Q2 		$463K Sell
12,352
-6,000
-33% -$189K 0.01% 310
2019
Q1 		$546K Buy
18,352
+6,616
+56% +$232K 0.01% 286
2018
Q4 		$351K Sell
11,736
-4,600
-28% -$146K 0.01% 324
2018
Q3 		$584K Buy
16,336
+2,392
+17% +$74.2K 0.01% 293
2018
Q2 		$331K Buy
+13,944
New +$296K 0.01% 340
2017
Q3 		– Sell
-61,428
Closed -$1.12M – 440
2017
Q2 		$1.12M Sell
61,428
-38,524
-39% -$712K 0.02% 304
2017
Q1 		$2.12M Buy
99,952
+76,672
+329% +$1.5M 0.03% 242
2016
Q4 		$347K Buy
+23,280
New +$412K 0.01% 339

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Advisory Research's DXCM Position: Q3 2020 in Review

Advisory Research sold out of DexCom (DXCM) in Q3 2020, closing a stake of 2,280 shares — an estimated $231K sold.

Advisory Research first reported a position in DXCM in Q4 2016 and held it in 12 quarters. The position peaked at $2.12M in Q1 2017. 728 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

  • Advisory Research reported no remaining DexCom position as of Q3 2020 after selling out during the quarter.
  • Advisory Research sold 2,280 DexCom shares in Q3 2020, an estimated $231K.
  • Advisory Research first reported a position in DexCom in Q4 2016 and held it in 12 quarters.
  • Advisory Research's DexCom position peaked at $2.12M in Q1 2017.
  • 728 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on Advisory Research's 13F filing for Q3 2020, filed 12 Nov 2020.